Derma Sciences, Inc. (DSCI) CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting of Shareholders
7/25/2014 9:08:59 AM
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announces that Edward J. Quilty, its chief executive officer, delivered a presentation highlighting MEDIHONEY® and its robust growth at the Comvita Ltd. annual meetings of shareholders in New Zealand on Thursday, July 24. During his remarks Mr. Quilty stated that the Company’s sales of MEDIHONEY dressings are expected to approach $20 million in 2014, which would represent an increase of approximately 23% compared with 2013 sales.
Help employers find you! Check out all the jobs and post your resume.
comments powered by